Analysis of Overall Survival Benefit of Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer

Ryan Sun, Dae Hyun Kim, Lee Jen Wei

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1121-1122
Number of pages2
JournalJAMA Oncology
Volume6
Issue number7
DOIs
StatePublished - Jul 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

MD Anderson CCSG core facilities

  • Biostatistics Resource Group

Cite this